Delivery Order SPE2DB22D2206-SPE2DB24FFG30
- Not listed
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the provision of Tobramycin 300 mg/5 ml ampules, a specialty pharmaceutical product, with a total potential value of $2,037.22. The contract has a period of performance through January 26, 2024. Amerisourcebergen Drug Corp holds a larger indefinite delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,604.14 to AmerisourceBergen Drug Corp for the supply of Tobramycin 300 mg/4 mL ampules on November 13, 2025, with completion expected by November 14, 2025. This delivery order, issued under a firm fixed-price arrangement with no set-aside designation, represents a competitively awarded transaction supporting federal pharmaceutical procurement needs. The product will be delivered to the company's facility in Conshohocken,...
- This is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $9,790.98 firm fixed-price contract is for the delivery of Tobramycin 1.2 GM vials, a pharmaceutical product used to treat bacterial infections. The delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which allows the agency to efficiently procure a...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The delivery order, valued at $1,157.19, is for the provision of Tobramycin Pak 300 mg/5 ml, a pharmaceutical product. The delivery order has a firm fixed price structure and a completion date of January 29, 2024. This award is not associated with a set-aside designation. Amerisourcebergen Drug Corp, as the prime...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The order is for 4,559,444,890 units of TOBRAMYCIN 300 MG/5 ML AMPULE, a pharmaceutical product, at a firm fixed price of $1,092.35. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora,...
- The Defense Logistics Agency awarded a delivery order valued at $3,061.26 to AmerisourceBergen Drug Corp for Tobramycin 1.2 GM vials, a critical antibiotic pharmaceutical product. This contract was competitively awarded on November 5, 2025, with an ultimate completion date of November 6, 2025, and utilizes firm fixed pricing with no set-aside designation. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a...
- This is a $1,023.08 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for Tobramycin-Dexameth Ophth Susp 5ML, a pharmaceutical product, with a period of performance through May 19, 2025. The contract is not set aside and was competitively awarded. Amerisourcebergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
- This federal contract award is for the delivery of the pharmaceutical product "TOBRAMYCIN PAK 300 MG/5 ML 5ML" to the Defense Logistics Agency (DLA) on a Firm Fixed Price basis. The award, valued at $26,338.56, was made to AmerisourceBergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $2,638.42 firm fixed price delivery order is for the supply of 4.5 gram vials of the antibiotic Piperacil-Tazobact. The contract is non-set-aside and has an ultimate completion date of July 10, 2025. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of pharmaceuticals, medical supplies, and related distribution services in support of military treatment programs and facilities. The contract has a ceiling value of $7,546.40 and a period of performance through March 19, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FFG30Delivery Order
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Tobramycin 300 mg/5 ml ampules. The contract has a potential value of $9,313.23 and a performance period through January 26, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This specific delivery order was issued under that IDC. No small business set-aside designation was used for this award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.3k | 1/25/24 |